MANESCHI, ELENA
MANESCHI, ELENA
Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio'
Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
2017 Comeglio, P; Filippi, S; Sarchielli, E; Morelli, A; Cellai, I; Corcetto, F; Corno, C; Maneschi, E; Pini, A; Adorini, L; Vannelli, Gabriella B; Maggi, M; Vignozzi, L
Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension.
2017 Vignozzi, Linda; Morelli, Annamaria; Cellai, Ilaria; Filippi, Sandra; Comeglio, Paolo; Sarchielli, Erica; Maneschi, Elena; Vannelli, Gabriella; Adorini, L; Maggi, Mario
Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation.
2013 Vignozzi L; Gacci M; Cellai I; Santi R; Corona G; Morelli A; Rastrelli G; Comeglio P; Sebastanelli A; Maneschi E; Nesi G; De Nunzio C; Tubaro A; Mannucci E; Carini M; Maggi M.
FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS.
2013 Maneschi, E; Vignozzi, L; Morelli, A; Mello, T; Filippi, S; Cellai, I; Comeglio, P; Sarchielli, E; Calcagno, A; Mazzanti, B; Vettor, R; Vannelli, Gb; Adorini, L; Maggi, M.
Il trattamento con testosterone o oca migliora le alterazioni del tessuto adiposo viscerale indotte dalla sindrome metabolica attraverso la normalizzazione dell’insulino-sensibilità: uno studio sperimentale nel coniglio
2015 Elena Maneschi
INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function
2018 Comeglio, Paolo; Cellai, Ilaria; Mello, Tommaso; Filippi, Sandra; Maneschi, Elena; Corcetto, Francesca; Corno, Chiara; Sarchielli, Erica; Morelli, Annamaria; Rapizzi, Elena; Bani, Daniele; Guasti, Daniele; Vannelli, Gabriella Barbara; Galli, Andrea; Adorini, Luciano; Maggi, Mario; Vignozzi, Linda
Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit.
2013 Morelli A; Comeglio P; Filippi S; Sarchielli E; Vignozzi L; Maneschi E; Cellai I; Gacci M; Lenzi A; Vannelli GB; Maggi M.
Metformin in vitro and in vivo increases adenosine signaling in rabbit corpora cavernosa.
2014 Vignozzi, L; Filippi, S; Comeglio, P; Cellai, I; Morelli, A; Rastrelli, G; Maneschi, E; Mannucci, E; Maggi, M.
Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit.
2014 Vignozzi L; Filippi S; Comeglio P; Cellai I; Sarchielli E; Morelli A; Rastrelli G; Maneschi E; Galli A; Vannelli GB; Saad F; Mannucci E; Adorini L; Maggi M.
Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: A role for GPR30/GPER?
2014 Comeglio P; Morelli A; Cellai I; Vignozzi L; Sarchielli E; Filippi S; Maneschi E; Corcetto F; Corno C; Gacci M; Vannelli GB; Maggi M
PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS.
2013 Vignozzi L; Gacci M; Cellai I; Morelli A; Maneschi E; Comeglio P; Santi R; Filippi S; Sebastianelli A; Nesi G; Serni S; Carini M; Maggi M
Tadalafil effect on metabolic syndrome-associated bladder alterations: an experimental study in a rabbit model.
2014 Vignozzi, L; Filippi, S; Comeglio, P; Cellai, I; Morelli, A; Maneschi, E; Sarchielli, E; Gacci, M; Carini, M; Vannelli, Gb; Maggi, M.
Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome.
2012 Morelli, Annamaria; Comeglio, Paolo; Filippi, Sandra; Sarchielli, Erica; Cellai, Ilaria; Vignozzi, Linda; Yehiely Cohen, R; Maneschi, Elena; Gacci, M; Carini, Marco; Adorini, L; Vannelli, Gabriella; Maggi, Mario
Testosterone protects from metabolic syndrome-associated prostate inflammation: An experimental study in rabbit
2012 Vignozzi, Linda; Morelli, Annamaria; Sarchielli, Erica; Comeglio, Paolo; Filippi, Sandra; Cellai, Ilaria; Maneschi, Elena; Serni, Sergio; Gacci, Mauro; Carini, Marco; Piccinni, MARIE-PIERRE; Saad, Farid; Adorini, Luciano; Vannelli, Gabriella B.; Maggi, Mario
Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements.
2012 Maneschi, E; Morelli, A; Filippi, S; Cellai, I; Comeglio, P; Mazzanti, B; Mello, T; Calcagno, A; Sarchielli, E; Vignozzi, L; Saad, F; Vettor, R; Vannelli, Gb; Maggi, M.
Testosterone/Estradiol Ratio Regulates NO-Induced Bladder Relaxation and Responsiveness to PDE5 Inhibitors.
2012 Vignozzi, L; Filippi, S; Morelli, A; Comeglio, P; Cellai, I; Sarchielli, E; Maneschi, E; Mancina, R; Gacci, M; Vannelli, Gb; Maggi, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis. | 2017 | Comeglio, P; Filippi, S; Sarchielli, E; Morelli, A; Cellai, I; Corcetto, F; Corno, C; Maneschi, E; Pini, A; Adorini, L; Vannelli, Gabriella B; Maggi, M; Vignozzi, L | |
| Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension. | 2017 | Vignozzi, Linda; Morelli, Annamaria; Cellai, Ilaria; Filippi, Sandra; Comeglio, Paolo; Sarchielli, Erica; Maneschi, Elena; Vannelli, Gabriella; Adorini, L; Maggi, Mario | |
| Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation. | 2013 | Vignozzi L; Gacci M; Cellai I; Santi R; Corona G; Morelli A; Rastrelli G; Comeglio P; Sebastanelli A; Maneschi E; Nesi G; De Nunzio C; Tubaro A; Mannucci E; Carini M; Maggi M. | |
| FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS. | 2013 | Maneschi, E; Vignozzi, L; Morelli, A; Mello, T; Filippi, S; Cellai, I; Comeglio, P; Sarchielli, E; Calcagno, A; Mazzanti, B; Vettor, R; Vannelli, Gb; Adorini, L; Maggi, M. | |
| Il trattamento con testosterone o oca migliora le alterazioni del tessuto adiposo viscerale indotte dalla sindrome metabolica attraverso la normalizzazione dell’insulino-sensibilità: uno studio sperimentale nel coniglio | 2015 | Elena Maneschi | |
| INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function | 2018 | Comeglio, Paolo; Cellai, Ilaria; Mello, Tommaso; Filippi, Sandra; Maneschi, Elena; Corcetto, Francesca; Corno, Chiara; Sarchielli, Erica; Morelli, Annamaria; Rapizzi, Elena; Bani, Daniele; Guasti, Daniele; Vannelli, Gabriella Barbara; Galli, Andrea; Adorini, Luciano; Maggi, Mario; Vignozzi, Linda | |
| Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit. | 2013 | Morelli A; Comeglio P; Filippi S; Sarchielli E; Vignozzi L; Maneschi E; Cellai I; Gacci M; Lenzi A; Vannelli GB; Maggi M. | |
| Metformin in vitro and in vivo increases adenosine signaling in rabbit corpora cavernosa. | 2014 | Vignozzi, L; Filippi, S; Comeglio, P; Cellai, I; Morelli, A; Rastrelli, G; Maneschi, E; Mannucci, E; Maggi, M. | |
| Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit. | 2014 | Vignozzi L; Filippi S; Comeglio P; Cellai I; Sarchielli E; Morelli A; Rastrelli G; Maneschi E; Galli A; Vannelli GB; Saad F; Mannucci E; Adorini L; Maggi M. | |
| Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: A role for GPR30/GPER? | 2014 | Comeglio P; Morelli A; Cellai I; Vignozzi L; Sarchielli E; Filippi S; Maneschi E; Corcetto F; Corno C; Gacci M; Vannelli GB; Maggi M | |
| PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS. | 2013 | Vignozzi L; Gacci M; Cellai I; Morelli A; Maneschi E; Comeglio P; Santi R; Filippi S; Sebastianelli A; Nesi G; Serni S; Carini M; Maggi M | |
| Tadalafil effect on metabolic syndrome-associated bladder alterations: an experimental study in a rabbit model. | 2014 | Vignozzi, L; Filippi, S; Comeglio, P; Cellai, I; Morelli, A; Maneschi, E; Sarchielli, E; Gacci, M; Carini, M; Vannelli, Gb; Maggi, M. | |
| Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome. | 2012 | Morelli, Annamaria; Comeglio, Paolo; Filippi, Sandra; Sarchielli, Erica; Cellai, Ilaria; Vignozzi, Linda; Yehiely Cohen, R; Maneschi, Elena; Gacci, M; Carini, Marco; Adorini, L; Vannelli, Gabriella; Maggi, Mario | |
| Testosterone protects from metabolic syndrome-associated prostate inflammation: An experimental study in rabbit | 2012 | Vignozzi, Linda; Morelli, Annamaria; Sarchielli, Erica; Comeglio, Paolo; Filippi, Sandra; Cellai, Ilaria; Maneschi, Elena; Serni, Sergio; Gacci, Mauro; Carini, Marco; Piccinni, MARIE-PIERRE; Saad, Farid; Adorini, Luciano; Vannelli, Gabriella B.; Maggi, Mario | |
| Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements. | 2012 | Maneschi, E; Morelli, A; Filippi, S; Cellai, I; Comeglio, P; Mazzanti, B; Mello, T; Calcagno, A; Sarchielli, E; Vignozzi, L; Saad, F; Vettor, R; Vannelli, Gb; Maggi, M. | |
| Testosterone/Estradiol Ratio Regulates NO-Induced Bladder Relaxation and Responsiveness to PDE5 Inhibitors. | 2012 | Vignozzi, L; Filippi, S; Morelli, A; Comeglio, P; Cellai, I; Sarchielli, E; Maneschi, E; Mancina, R; Gacci, M; Vannelli, Gb; Maggi, M. |